Inventor

Walfred S. Saari

Inventor
Lansdale, PA, US

Overview

52→
Patents
1976–1996
Patent span
Chemistry
Primary field (CPC C)

Patents· 52 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds51%
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
C07CAcyclic or carbocyclic compounds10%
C07KPeptides6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
C07HSugars1%
C07JSteroids1%
PatentTitleYear
5,576,313'Inhibitors of farnesyl-protein transferase'19965,527,819'Inhibitors of HIV reverse transcriptase'19965,495,047'Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy'19965,308,854'Inhibitors of HIV reverse transcriptase'19945,227,506'Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors'19935,183,815'Bone acting agents'19935,028,692'Gastrin releasing peptide antagonist'19915,019,647'Gastrin releasing peptide antagonist'19914,943,561'Gastrin releasing peptide antagonist'19904,942,226'Halogenated pyrimidine nucleosides and their derivatives'19904,935,443'N-substituted-3-nitro-4-(ureidooxymethyl)-benzenesulfonamides as radiation enhancers'19904,897,423'Dinitrobenzenesulfonamides'19904,892,951'Derivatives of 3-nitropyridines useful as adjuncts to radiation therapy'19904,880,821'.alpha.-nitroalkylnitrobenzenesulfonamides'19894,853,415'2-(substituted sulfamyl) derivatives of 4-nitrobenzamide as radiation sensitizers'19894,847,294'Derivatives of 2-(substituted sulfamyl)-6-nitrobenzoic acids, useful as adjuncts to radiation therapy'19894,845,284'Substituted 3-nitrobenzenesulfonamides useful as adjuncts in radiation therapy'19894,812,590'Carbamates of 4-hydroxyanisole as prodrugs for chemotherapy of melanoma'19894,731,369'Amides and esters of 2-(N-(hydroxypiperidinoalkyl) and (hydroxypyrrolidinoalkyl)-aminosulfonyl)-6-nitrobenzoic acids useful as adjuncts to radiation therapy'19884,694,020'Derivatives of 2-(substituted sulfamyl)-6-nitrobenzoic acids and pharmaceutical compositions'19874,654,369'Esters of 2-(substituted sulfamyl)-6-nitro-benzoic acid and pharmaceutical compositions'19874,647,588'2-(substituted sulfamyl)-6-nitrobenzoic acid amides and pharmaceutical compositions'19874,619,927'Novel nitropyrazinyl- and nitropyridinyl- substituted piperazin-3-one and hexahydro-1H-1,4-diazepin-5-one compounds useful as adjuncts to radiation therapy'19864,603,133'Amides and esters of 2-[N-(morpholinoalkyl)aminosulfonyl]-6-nitrobenzoic acids and compositions useful as adjuncts to radiation therapy'19864,505,918'4-[2-Pyridinylthio(oxy or amino)methyl]-1H-imidazoles and derivatives'19854,506,074'2-[2-Pyridinyloxy(thio or amino)methyl]-1H-imidazoles and derivatives'19854,483,858'8-[2-Imidazolylmethyloxy(thio, or amino)]-imidazo[1,2-a]pyrazines and derivatives for treating hypertension'19844,456,604'1-(3-Halo-2-pyridinyl) piperazine'19844,442,103'Treating sedation with 1-(3-substituted-2-pyridinyl) piperazines'19844,381,302'(6a.alpha.,10a.alpha.,11a.alpha.)-2-(2-Pyridinyl)-1,3,4,6,6a,7,8,9,10,10 a,11,11a-dodecahydro-2H-pyrazino]1,2-b]isoquinoline and derivatives'19834,376,772'Use of piperazinyl-imidazo[1,2-a]pyrazines in sedation'19834,302,455'2-(4-Aminopiperidino)pyrazines'19814,252,816'Tetrahydro-1H-1,4-diazepino(1,7-a)benzimidazoles useful as analgesic agents'19814,251,530'2-{[4-(6-Substituted-2-pyrazinyl)- 1-piperazinyl]alkyl}-5-substituted-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one analgesic agents'19814,198,413'Amino acid esters'19804,187,315'N-alkyl(and cycloalkyl)oxamic acid and derivatives as inhibitors of glycolic acid oxidase'19804,163,849'Piperazinylpyrazines'19794,160,712'Process for preparing novel N-carboxyl-.alpha.-amino acid anhydrides'19794,143,146'Esters of .alpha.-methyl-3,4-OR-phenylalanines'19794,120,971'Novel N-carboxy-alpha-amino acid anhydrides'19784,091,101'6-(1-Piperazinyl)quinoxaline'19784,082,845'3-(1-Piperazinyl)-pyrido[2,3-b]pyrazines'19784,082,844'6-Chloro-2-(1-piperazinyl)pyrazine'19784,081,542'Piperazinylpyrazines'19784,078,063'Piperazinylpyridines'19784,065,464'Process for the preparation of substituted trichloroacetamidine derivatives'19774,058,530'Amino acid esters'19774,051,169'Amino acid esters'19774,038,411'Antihypertensive amino acid esters'19773,988,341'Esterification process'19763,983,138'Amino acid esters'19763,976,782'3-(2,5-Dihydroxyphenyl)-alanine as a cardiac stimulant'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976–1996Patents assigned to MERCK & CO INC (51)· patent assignee history
1976–1996Based in Lansdale, PA, US· patent location history
1978Based in Pennsburg, PA, US· patent location history
1989Based in Landsdale, PA, US· patent location history
1996Patents assigned to MERCK SHARP & DOHME (1)· patent assignee history
1996Based in St. George, ME, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK & CO INC511976–1996
MERCK SHARP & DOHME11996
Locations
LocationPatentsSpan
Lansdale, Pennsylvania, US491976–1996
St. George, ME, US11996
Landsdale, Pennsylvania, US11989
Pennsburg, Pennsylvania, US11978